Cannabis Europa had its ninth edition this week, returning to the Barbican Centre for the first time since it began in 2018. It attracted over a thousand business executives, important EU policymakers, and patient advocates.
Prohibition Partners CEO Stephen Murphy gave a warm welcome to guests at the Barbican theatre, praising the location as a “beacon for creativity” in the UK and emphasising the importance of creativity in the cannabis sector. Mr. Murphy reflected on the first Cannabis Europa in 2018, noting that there were “little to no patients, companies, or regulations” throughout the EU. While it is simple to become irritated at the industry’s lack of change and pace, he suggested we must keep in mind how far it has come in this brief amount of time. Additionally, he emphasised that the sector must continue to place patients at the core of its business models and that there is still a need for patient integration across the board.